Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care

OBJECTIVE: Approximately 5% of patients with coronavirus disease 2019 (COVID-19) develop a life-threatening pneumonia that often occurs in the setting of increased inflammation or “cytokine storm”. Anti-cytokine treatments are being evaluated but optimal patient selection remains unclear, and the ai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Virol
Autores principales: Quartuccio, Luca, Sonaglia, Arianna, McGonagle, Dennis, Fabris, Martina, Peghin, Maddalena, Pecori, Davide, De Monte, Amato, Bove, Tiziana, Curcio, Francesco, Bassi, Flavio, De Vita, Salvatore, Tascini, Carlo
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227535/
https://ncbi.nlm.nih.gov/pubmed/32570043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104444
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares